Empfehlungen zu SARS-CoV-2/COVID-19 in Schwangerschaft,
                    Geburt und Wochenbett – Update November 2021
                    (Kurzfassung)

Janine Zöllkau; Carsten Hagenbeck; Kurt Hecher; Ulrich Pecks; Dietmar Schlembach; Arne Simon; Rolf Schlösser; Ekkehard Schleußner

doi:10.1055/a-1687-2233

Zeitschrift für Geburtshilfe und Neonatologie, Inhaltsverzeichnis

Z Geburtshilfe Neonatol 2022; 226(01): 16-24
DOI: 10.1055/a-1687-2233

Leitlinie

Empfehlungen zu SARS-CoV-2/COVID-19 in Schwangerschaft, Geburt und Wochenbett – Update November 2021 (Kurzfassung)

Recommendations for SARS-CoV-2/COVID-19 during Pregnancy, Birth and Childbed – Update November 2021 (Short Version)

Janine Zöllkau‡

¹Klinik für Geburtsmedizin, Universitätsklinikum Jena, Deutschland

,

Carsten Hagenbeck‡

²Klinik für Frauenheilkunde und Geburtshilfe, Universität Düsseldorf, Deutschland

,

Kurt Hecher

³Klinik für Geburtshilfe und Pränatalmedizin, Universitätsklinikum Hamburg-Eppendorf, Deutschland

,

Ulrich Pecks

⁴Klinik für Gynäkologie und Geburtshilfe, Campus Kiel, Universitätsklinikum Schleswig-Holstein, Deutschland

,

Dietmar Schlembach

⁵Klinik für Geburtsmedizin, Vivantes Klinikum Neukölln, Berlin, Deutschland

,

Arne Simon

⁶Klinik für Pädiatrische Onkologie und Hämatologie, Universitätsklinikum des Saarlandes, Homburg/Saar, Deutschland

,

Rolf Schlösser

⁷Schwerpunkt Neonatologie, Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Frankfurt, Deutschland

,

Ekkehard Schleußner

¹Klinik für Geburtsmedizin, Universitätsklinikum Jena, Deutschland

› Institutsangaben

Abstract

Zusammenfassung

Seit Beginn der SARS-CoV-2-Pandemie haben die Deutsche Gesellschaft für Gynäkologie und Geburtshilfe und die Gesellschaft für Peri-/Neonatalmedizin Empfehlungen zum Umgang mit SARS-CoV-2-positiven Schwangerschaften und Neugeborenen veröffentlicht und wiederholt aktualisiert. Als Weiterführung der bestehenden Empfehlungen werden in dem aktuellen Update Schlüsselfragen zur prä-, peri- und postnatalen Versorgung von Schwangeren, Gebärenden, Wöchnerinnen, Stillenden mit SARS-CoV-2 und COVID-19 sowie deren Un- oder Neugeborenen auf der Grundlage von Veröffentlichungen bis zum September 2021 behandelt. Die Empfehlungen und Stellungnahmen wurden sorgfältig aus den aktuell verfügbaren wissenschaftlichen Daten abgeleitet und anschließend im Expertenkonsens verabschiedet. Dieser Leitfaden – hier in der Kurzfassung vorliegend – soll eine Hilfe für die klinische Entscheidungsfindung darstellen. Die Auslegung und therapeutische Verantwortung obliegen weiterhin dem betreuenden medizinischen Team vor Ort, dessen Entscheidungen durch diese Empfehlungen unterstützt werden sollen. Aufgrund der raschen Dynamik neuer Erkenntnisse kann eine Anpassung erforderlich sein. Die Empfehlungen werden durch die Zustimmung der Fachgesellschaften getragen: Deutsche Gesellschaft für Perinatale Medizin (DGPM), Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), Deutsche Gesellschaft für Pränatal- und Geburtsmedizin (DGPGM), Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI), Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin (GNPI).

Abstract

Since the onset of the SARS-CoV-2 pandemic, the German Society of Gynecology and Obstetrics and the Society for Peri-/Neonatal Medicine have published and repeatedly updated recommendations for the management of SARS-CoV-2 positive pregnancies and neonates. As a continuation of existing recommendations, the current update addresses key issues related to the prenatal, perinatal, and postnatal care of pregnant women, women who have recently given birth, women who are breastfeeding with SARS-CoV-2 and COVID-19, and their unborn or newborn infants, based on publications through September 2021. Recommendations and opinions were carefully derived from currently available scientific data and subsequently adopted by expert consensus. This guideline – here available in the short version – is intended to be an aid to clinical decision making. Interpretation and therapeutic responsibility remain with the supervising local medical team, whose decisions should be supported by these recommendations. Adjustments may be necessary due to the rapid dynamics of new evidence. The recommendations are supported by the endorsement of the professional societies: German Society for Perinatal Medicine (DGPM), German Society of Gynecology and Obstetrics (DGGG), German Society for Prenatal and Obstetric Medicine (DGPGM), German Society for Pediatric Infectiology (DGPI), Society for Neonatology and Pediatric Intensive Care Medicine (GNPI).

Schlüsselwörter

SARS-CoV-2 - COVID-19 - Schwangerschaft - Geburt - Wochenbett - Stillen, Impfung

Key words

SARS-CoV-2 - COVID-19 - pregnancy - birth - childbed - breastfeeding - vaccination

Volltext

Referenzen

Literatur
1 Takla AM-KD, Bogdan C, Harder T. et al. Empfehlung und Begründung der STIKO zur Impfung gegen COVID- 19 von Schwangeren und Stillenden. Epid Bull 2021; 38: 10-36
2 Beig Parikhani A, Bazaz M, Bamehr H. et al. The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options. Curr Microbiol 2021; 78: 1099-1114
3 Cochrane. COVID-19 review of national clinical practice guidelines for key questions relating to the care of pregnant women and their babies: Cochrane; 2020 [International Consensus]. Available from: https://pregnancy.cochrane.org/news/covid-19-review-national-clinical-practice-guidelines-key-questions-relating-care-pregnant
4 RKI. Erweiterte Hygienemaßnahmen im Gesundheitswesen im Rahmen der COVID-19 Pandemie 2020 [updated 05/13/2020. Available from: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/erweiterte_Hygiene.html
5 Boelig RC, Saccone G, Bellussi F. et al. MFM guidance for COVID-19. Am J Obstet Gynecol MFM 2020; 100106
6 DGGG. Empfohlene Präventionsmaßnahmen für die geburtshilfliche Versorgung in deutschen Krankenhäusern und Kliniken im Zusammenhang mit dem Coronavirus 16.03.2020. 2020 [updated 03/16/2020. Available from: https://www.dggg.de/fileadmin/documents/Weitere_Nachrichten/2020/COVID-19_DGGG- Empfehlungen_fuer_Kreissaele_20200319_f.pdf
7 DGPI. Umgang mit Neugeborenen SARS-CoV-2 positiver Mütter mit oder ohne klinische Erkrankung (COVID-19) 2020 [updated 03/31/2020. Available from: https://dgpi.de/stellungnahme-dgpi-dggg-dgpm-umgang-mit-neugeborenen-sars-cov-2-positiver-muetter/
8 RKI. COVID-19 (Coronavirus SARS-CoV-2) 2020 [updated 06222020. Available from: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/nCoV.html
9 Jamieson DJ, Steinberg JP, Martinello RA. et al. Obstetricians on the Coronavirus Disease 2019 (COVID-19) Front Lines and the Confusing World of Personal Protective Equipment. Obstet Gynecol 2020; 135: 1257-1263
10 Kagan KO, Chaoui R. Ultraschall in der Schwangerschaft wahrend der Corona-Virus Pandemie: Ein praktisches Vorgehen. Ultraschall Med. 2020
11 Bourne T, Leonardi M, Kyriacou C. et al. ISUOG Consensus Statement on rationalization of gynecological ultrasound services in context of SARS-CoV-2. Ultrasound Obstet Gynecol 2020; 55: 879-885
12 Shanes ED, Mithal LB, Otero S. et al. Placental Pathology in COVID-19. Am J Clin Pathol. 2020
13 CDC. Interim Considerations for Infection Prevention and Control of Coronavirus Disease 2019 (COVID-19) in Inpatient Obstetric Healthcare Settings. 2020
14 McIntosh JJ. Corticosteroid Guidance for Pregnancy during COVID-19 Pandemic. Am J Perinatol 2020; 37: 809-812
15 D’Souza R, Ashraf R, Rowe H. et al. Pregnancy and COVID-19: Pharmacologic Considerations. Ultrasound Obstet Gynecol. 2020
16 Schleussner E. The prevention, diagnosis and treatment of premature labor. Dtsch Arztebl Int 2013; 110: 227-235 quiz 36
17 Berghella V. Coronavirus disease 2019 (COVID-19): Pregnancy issues UpToDate^®: UpToDate, Inc.; 2020 [updated May 27, 2020. Literature review current through: Apr 2020:[Available from: https://www.uptodate.com/contents/coronavirus-disease-2019-covid- 19-pregnancy-issues?search=covid%2019%20pregnancy&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
18 D’Souza R, Malhame I, Teshler L. et al. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstet Gynecol Scand 2020; 99: 1110-1120
19 Bikdeli B, Madhavan MV, Jimenez D. et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol 2020; 75: 2950-2973
20 Metz TD, Clifton RG, Hughes BL. et al. Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID- 19). Obstet Gynecol 2021; 137: 571-580
21 Servante J, Swallow G, Thornton JG. et al. Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysis. BMC Pregnancy Childbirth 2021; 21: 108
22 D’Souza R, Malhame I, Teshler L. et al. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstet Gynecol Scand. 2020
23 Bongiovanni D, Klug M, Lazareva O. et al. SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype. Cell Death Dis 2021; 12: 50
24 Perico L, Benigni A, Casiraghi F. et al. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol 2021; 17: 46-64
25 RCOG. Coronavirus (COVID-19) Infection in Pregnancy 2020 [updated 06/04/2020. Version 10:[Available from: https://www.rcog.org.uk/globalassets/documents/guidelines/2020-06-04-coronavirus-covid-19-infection-in-pregnancy.pdf
26 Kadir RA, Kobayashi T, Iba T. et al. COVID-19 Coagulopathy in Pregnancy: Critical Review, Preliminary Recommendations and ISTH Registry - Communication from the ISTH SSC for Women’s Health. J Thromb Haemost. 2020
27 Kaptein FHJ, Stals MAM, Huisman MV. et al. Prophylaxis and treatment of COVID-19 related venous thromboembolism. Postgrad Med 2021; 133: 27-35
28 Thachil J, Tang N, Gando S. et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 2020; 18: 1023-1026
29 Knol HM, Schultinge L, Erwich JJ. et al. Fondaparinux as an alternative anticoagulant therapy during pregnancy. J Thromb Haemost 2010; 8: 1876-1879
30 AWMF. S3-Leitlinie - Empfehlungen zur stationären Therapie von Patienten mit COVID- 19 AWMF-Register-Nr 113/001 2021.
31 Iba T, Levy JH, Levi M. et al. Coagulopathy of Coronavirus Disease 2019. Crit Care Med 2020; 48: 1358-1364
32 Pourafkari L, Mirza-Aghzadeh-Attari M, Zarrintan A. et al. Clinical Experience, Pathophysiology, and Considerations in the Prophylaxis and Treatment of Hypercoagulopathy of COVID-19: A Review Study. Iran J Med Sci 2021; 46: 1-14
33 Donders F, Lonnee-Hoffmann R, Tsiakalos A. et al. ISIDOG Recommendations Concerning COVID-19 and Pregnancy. Diagnostics (Basel) 2020; 10: 243
34 Stephens AJ, Barton JR, Bentum NA. et al. General Guidelines in the Management of an Obstetrical Patient on the Labor and Delivery Unit during the COVID-19 Pandemic. Am J Perinatol. 2020
35 Oxford-Horrey C, Savage M, Prabhu M. et al. Putting It All Together: Clinical Considerations in the Care of Critically Ill Obstetric Patients with COVID-19. Am J Perinatol 2020; 37: 1044-1051
36 Elshafeey F, Magdi R, Hindi N. et al. A systematic scoping review of COVID-19 during pregnancy and childbirth. Int J Gynaecol Obstet. 2020
37 Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020
38 Jafari M, Pormohammad A, Sheikh Neshin SA. et al. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis. Rev Med Virol 2021; 31: 1-16
39 Cunarro-Lopez Y, Pintado-Recarte P, Cueto-Hernandez I. et al. The Profile of the Obstetric Patients with SARS-CoV- 2 Infection According to Country of Origin of the Publication: A Systematic Review of the Literature. J Clin Med 2021; 10: 360
40 Capobianco G, Saderi L, Aliberti S. et al. COVID-19 in pregnant women: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2020; 252: 543-558
41 Dubey P, Reddy SY, Manuel S. et al. Maternal and neonatal characteristics and outcomes among COVID-19 infected women: An updated systematic review and meta- analysis. Eur J Obstet Gynecol Reprod Biol 2020; 252: 490-501
42 Knight M, Bunch K, Vousden N. et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ 2020; 369: m2107
43 Remaeus K, Savchenko J, Brismar Wendel S. et al. Characteristics and short-term obstetric outcomes in a case series of 67 women tested positive for SARS-CoV-2 in Stockholm, Sweden. Acta Obstet Gynecol Scand. 2020
44 DGPM. CRONOS Registerstudie [Vorläufiger Datenstand 21.08.2021 (abschließende Auswertung ausstehend):[Available from: https://www.dgpm-online.org/gesellschaft/covid-19/cronos-registerstudie/
45 Ferrazzi E, Frigerio L, Savasi V. et al. Vaginal delivery in SARS-CoV-2 infected pregnant women in Northern Italy: a retrospective analysis. BJOG. 2020
46 Edward Morris POB, Gemma Goodyear, Sophie Relph, Jennifer Jardine, Anita Powell, Emma Gilgunn-Jones, Ed Mullins, Russell Viner, David Evans, Mary Ross-Davie. Coronavirus (COVID-19) Infection in Pregnancy - Information for healthcare professionals 2020 [updated 05/13/2020. Available from: https://www.rcog.org.uk/globalassets/documents/guidelines/2020-05-13-coronavirus-covid-19-infection-in-pregnancy.pdf
47 Gracia-Perez-Bonfils A, Martinez-Perez O, Llurba E. et al. Fetal heart rate changes on the cardiotocograph trace secondary to maternal COVID-19 infection. Eur J Obstet Gynecol Reprod Biol 2020; 252: 286-293
48 Colon-Aponte C, Saad A, Ndubizu C. et al. SARS-CoV-2 in pregnancy, placental fetal vascular malperfusion and the effect on fetal heart rate tracings. American Journal of Obstetrics and Gynecology 2021; 224: S374-S374
49 Britton GJ, Chen-Liaw A, Cossarini F. et al. Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19. medRxiv. 2020
50 Barth RE, De Regt MJA. Persistence of viral RNA in stool samples from patients recovering from covid-19. BMJ 2020; 369: m1724
51 Amirian ES. Potential fecal transmission of SARS-CoV-2: Current evidence and implications for public health. Int J Infect Dis 2020; 95: 363-370
52 Docherty AB, Harrison EM, Green CA. et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020; 369: m1985
53 Cai J, Tang M, Gao Y. et al. Cesarean Section or Vaginal Delivery to Prevent Possible Vertical Transmission From a Pregnant Mother Confirmed With COVID-19 to a Neonate: A Systematic Review. Front Med (Lausanne) 2021; 8: 634949
54 Rottenstreich A, Tsur A, Braverman N. et al. Vaginal delivery in SARS-CoV-2-infected pregnant women in Israel: a multicenter prospective analysis. Arch Gynecol Obstet 2021; 303: 1401-1405
55 Villar J, Ariff S, Gunier RB. et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr 2021; 175: 817-826
56 Cuerva MJ, Carbonell M, Martin Palumbo G. et al. Personal Protective Equipment during the COVID-19 pandemic and operative time in cesarean section: retrospective cohort study. J Matern Fetal Neonatal Med 2020; 1-4
57 Sutton D, Fuchs K, D’Alton M. et al. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery. N Engl J Med. 2020
58 Khalil A, Hill R, Ladhani S. et al. SARS-CoV-2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg. Am J Obstet Gynecol. 2020
59 e.V. DGfA-uV. COVID-19 Empfehlung der DGAV e.V. 2020 [updated 04/24/2020. Available from: https://www.awmf.org/fileadmin/user_upload/Stellungnahmen/Medizinische_Versorgung/DGAV_COVID_Empfehlung2.pdf
60 e.V. PDGfGuG. DGGG EMPFIEHLT: VÄTER BEI DER GEBURT ZULASSEN – AUCH IN ZEITEN DER CORONA-PANDEMIE 2020 [Pressemitteilung der DGGG]. Available from: https://www.dggg.de/presse-news/pressemitteilungen/mitteilung/dggg-empfiehlt-vaeter-bei-der-geburt-zulassen-auch-in-zeiten-der-corona-pandemie-1195/
61 Stillkommission N. Stillen und COVID-19 – Stellungnahme der Nationalen Stillkommission vom 11. März 2020 2020 [updated 03/11/2020. Available from: https://www.mri.bund.de/de/themen/nationale-stillkommission/stellungnahmen/stillen- covid-19/
62 Mayopoulos G, Ein-Dor T, Li K. et al. Giving birth under hospital visitor restrictions: Heightened acute stress in childbirth in COVID-19 positive women. Res Sq. 2020
63 Waterman RS, Brzenski A, Robbins K. et al. Recommendations for developing clinical care protocols during pandemics: From theory and practice. Best Pract Res Clin Anaesthesiol 2021; 35: 461-475
64 Martinez Santos L, Olabarrieta Zarain U, Garcia Trancho A. et al. Anesthetic planning and management for a caesarian section in a pregnant woman affected by SARS-COV-2 pneumonia. Rev Esp Anestesiol Reanim (Engl Ed) 2021; 68: 46-49
65 Peter Kranke SW, Sitter M, Meybohm P. et al. Obstetric Anesthesia During the SARS-CoV-2 Pandemic – a Brief Overview of Published Recommendations for Action by National and International Specialist Societies and Committees. Anästhesiol Intensivmed Notfallmed Schmerzther 2020; 55: 266-274
66 Morau E, Bouvet L, Keita H. et al. Anaesthesia and intensive care in obstetrics during the COVID-19 pandemic. Anaesth Crit Care Pain Med 2020; 39: 345-349
67 Magoon R, Choudhary N, Saxena K. Labour analgesia in COVID-19 positive parturients: Points to ponder!. Trends Anaesth Crit 2021; 38: 16-17
68 Landau R. COVID-19 Pandemic and Obstetric Anaesthesia. Anaesth Crit Care Pain Med 2020; 39: 327-328
69 Bauer ME, Bernstein K, Dinges E. et al. Obstetric Anesthesia During the COVID-19 Pandemic. Anesth Analg 2020; 131: 7-15
70 Mihaela Podovei KB, Ronald George, Ashraf Habib, Rachel Kacmar, Brian Bateman and Ruth Landau. Interim Considerations for Obstetric Anesthesia Care related to COVID19 [PDF]. 2020 [updated 05/22/2020. Available from: https://soap.org/wp-content/uploads/2020/05/SOAP_COVID-19_Obstetric_Anesthesia_Care_052220.pdf
71 RCOG TRCoOaG. Coronavirus (COVID-19) Infection in Pregnancy Information for healthcare professionals 2020 [Available from: https://www.rcog.org.uk/globalassets/documents/guidelines/2020-07-24-coronavirus-covid-19-infection-in-pregnancy.pdf
72 WHO. Q&A: Pregnancy, childbirth and COVID-19 2020 [updated 18 March 2020 Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/q-a-on-covid-19-pregnancy-and-childbirth
73 Benlolo S, Nensi A, Campbell DM. et al. The Use of In Situ Simulation to Enhance COVID-19 Pandemic Preparedness in Obstetrics. Cureus 2021; 13: e12906
74 ACOG. Novel Coronavirus 2019 (COVID-19) 2020 [updated 05/19/2020. Available from: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/03/novel-coronavirus-2019
75 Wolfel R, Corman VM, Guggemos W. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020; 581: 465-469
76 Arons MM, Hatfield KM, Reddy SC. et al. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med 2020; 382: 2081-2090
77 RKI. SARS-CoV-2 Steckbrief zur Coronavirus-Krankheit-2019 (COVID-19). 2020
78 (WHO) WHO. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected, interim guidance 27 May 2020 2020 [Available from: https://www.who.int/publications/i/item/clinical-management-of-covid-19
79 Gale C, Quigley MA, Placzek A. et al. Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance. Lancet Child Adolesc 2021; 5: 113-121
80 Martenot A, Labbassi I, Delfils-Stern A. et al. Pichault-Klein V, et al. Favorable outcomes among neonates not separated from their symptomatic SARS-CoV-2- infected mothers. Pediatric Research 2021; 90: 8-11
81 CDC. Care for newborns. 2020 [Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-newborns.html
82 ACOG. Summary of Key Updates (September 25,2020). 2020
83 Minckas N, Medvedev MM, Adejuyigbe EA. et al. Preterm care during the COVID-19 pandemic: A comparative risk analysis of neonatal deaths averted by kangaroo mother care versus mortality due to SARS-CoV-2 infection. Eclinicalmedicine 2021; 33
84 Wang YY, Chen L, Wu TC. et al. Impact of Covid-19 in pregnancy on mother’s psychological status and infant’s neurobehavioral development: a longitudinal cohort study in China. Bmc Medicine 2020; 18: 347
85 CDC. Coronavirus Disease 2019 (COVID-19) Evaluation and Management Considerations for Neonates At Risk for COVID-19. 2020 [Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-newborns.html
86 Mand N, Iannaccone A, Longardt AC. et al. Neonatal outcome following maternal infection with SARS-CoV-2 in Germany: COVID-19-Related Obstetric and Neonatal Outcome Study (CRONOS). Arch Dis Child Fetal Neonatal Ed. 2021
87 Williams J, Namazova-Baranova L, Weber M. et al. The Importance of Continuing Breastfeeding during Coronavirus Disease-2019: In Support of the World Health Organization Statement on Breastfeeding during the Pandemic. J Pediatr 2020; 223: 234-236
88 Peng S, Zhu H, Yang L. et al. A study of breastfeeding practices, SARS-CoV-2 and its antibodies in the breast milk of mothers confirmed with COVID-19. Lancet Reg Health West Pac 2020; 4: 100045
89 Bhatt H. Should COVID-19 Mother Breastfeed her Newborn Child? A Literature Review on the Safety of Breastfeeding for Pregnant Women with COVID-19. Curr Nutr Rep 2021; 10: 71-75
90 Haiek LN, LeDrew M, Charette C. et al. Shared decision-making for infant feeding and care during the coronavirus disease 2019 pandemic. Matern Child Nutr 2021; 17: e13129
91 Sanchez-Luna M, Fernandez Colomer B, de Alba Romero C. et al. Neonates Born to Mothers With COVID-19: Data From the Spanish Society of Neonatology Registry. Pediatrics 2021; 147: e2020015065
92 Cui Y, Tian M, Huang D. et al. Corrigendum to: A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage. J Infect Dis. 2020
93 Gross R, Conzelmann C, Muller JA. et al. Detection of SARS-CoV-2 in human breastmilk. Lancet. 2020
94 Martins-Filho PR, Santos VS, Santos HP. To breastfeed or not to breastfeed? Lack of evidence on the presence of SARS-CoV-2 in breastmilk of pregnant women with COVID-19. Rev Panam Salud Publica 2020; 44: e59
95 Chambers C, Krogstad P, Bertrand K. et al. Evaluation for SARS-CoV-2 in Breast Milk From 18 Infected Women. JAMA. 2020
96 Vasques da Costa A, Purcell Goes C, Gama P. Breastfeeding importance and its therapeutic potential against SARS-CoV-2. Physiol Rep 2021; 9: e14744
97 Dong Y, Chi X, Hai H. et al. Antibodies in the breast milk of a maternal woman with COVID-19. Emerg Microbes Infect 2020; 9: 1467-1469
98 Gao X, Wang S, Zeng W. et al. Clinical and immunologic features among COVID-19-affected mother-infant pairs: antibodies to SARS-CoV-2 detected in breast milk. New Microbes New Infect 2020; 37: 100752
99 Bertino E, Moro GE, De Renzi G. et al. Detection of SARS- CoV-2 in Milk From COVID-19 Positive Mothers and Follow-Up of Their Infants. Frontiers in Pediatrics 2020; 8
100 Fox A, Marino J, Amanat F. et al. Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk. Iscience 2020; 23
101 Demers-Mathieu V, DaPra C, Mathijssen GB. et al. Previous viral symptoms and individual mothers influenced the leveled duration of human milk antibodies cross-reactive to S1 and S2 subunits from SARS-CoV-2, HCoV-229E, and HCoV-OC43. Journal of Perinatology 2021; 41: 952-960
102 Quitadamo PA, Comegna L, Cristalli P. Anti-Infective, Anti-Inflammatory, and Immunomodulatory Properties of Breast Milk Factors for the Protection of Infants in the Pandemic From COVID-19. Frontiers in Public Health 2021; 8
103 Martins-Filho PR, Tanajura DM, Santos HP. et al. COVID-19 during pregnancy: Potential risk for neurodevelopmental disorders in neonates?. Eur J Obstet Gynecol Reprod Biol 2020; 250: 255-256